Log In
BCIQ
Print this Print this
 

Haempatch

  Manage Alerts
Collapse Summary General Information
Company QRxPharma Ltd.
DescriptionSnake venom components
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPreclinical
Standard IndicationBleeding
Indication DetailsPro-coagulants for the treatment of patients following surgery, acute hemorrhage and bleeding disorders
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$5.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/05/2009

Undisclosed

$5.0M

0

Get a free BioCentury trial today